Rennova Health, Inc. (RNVA) Stock Price & Analysis
Educational signal · not a buy or sell recommendation · How to read this
Market cap $4.31M is the value of all shares combined.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 15, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerRennova Health, Inc. (RNVA) trades at $0.0001. Rennova Health, Inc. operates healthcare facilities in the United States. The company focuses on providing services through its hospitals and clinics, primarily in Tennessee and Kentucky. Market cap: $4.31M, Sector: Healthcare.
Price as of · Last analyzed: Mar 15, 2026Analyst Coverage for RNVA: RNVA does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
Rennova Health, Inc. (RNVA) Healthcare & Pipeline Overview
Rennova Health, Inc. provides healthcare services through its hospitals and clinics, primarily operating in Tennessee and Kentucky. With a focus on acute care and rural healthcare access, the company faces challenges in a competitive landscape while striving to maintain patient care standards and navigate the evolving healthcare regulatory environment.
What Is the Investment Thesis for RNVA?
Rennova Health, Inc. presents a challenging investment case given its current financial metrics. The company's negative P/E ratio of -0.42 and a profit margin of -41.4% indicate significant profitability issues. While the gross margin of 59.5% suggests potential in its core operations, the company needs to address its cost structure and revenue generation. Key growth catalysts include expanding services within its existing facilities and potentially acquiring additional healthcare facilities. However, potential risks include regulatory compliance, competition, and the company's ability to achieve sustainable profitability. Investors should closely monitor Rennova Health's financial performance and strategic initiatives to assess its long-term viability.
Based on FMP financials and quantitative analysis
RNVA Key Highlights
Market capitalization of $4.31M indicates a small-cap company with potential for high volatility.
- Negative P/E ratio of -0.42 reflects current unprofitability.
- Profit margin of -41.4% highlights significant challenges in achieving profitability.
- Gross margin of 59.5% suggests potential in core operations if costs are managed effectively.
- Beta of -0.05 indicates low correlation with the overall market, potentially offering some downside protection.
Who Are RNVA's Competitors?
RNVA is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| CBSC Cardiac Biotech Solutions Inc. | $0.04 | 0.00% | $5.79M | — |
| IDXG Interpace Biosciences, Inc. | $6.03 | -5.71% | $33.4M | — |
| INBS Intelligent Bio Solutions Inc. | $1.66 | 0.00% | $5.51M | — |
| NDRA ENDRA Life Sciences Inc. | $6.06 | +3.06% | $7.70M | 32 5-pillar |
| ADVB Advanced Biomed Inc. Common Stock | $6.73 | -2.60% | $9.30M | 62 5-pillar |
| BNGO Bionano Genomics, Inc. | $1.48 | -5.73% | $17.0M | — |
| BNR Burning Rock Biotech Limited | $16.25 | +1.63% | $17.2M | — |
| MDXH MDxHealth SA | $0.57 | -0.90% | $29.3M | — |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are RNVA's Key Strengths?
Local presence in rural markets.
- Established healthcare facilities.
- Focus on underserved populations.
- Gross margin of 59.5%.
What Are RNVA's Weaknesses?
Negative P/E ratio of -0.42.
- Profit margin of -41.4%.
- Limited geographic reach.
- Small market capitalization.
What Are the Key Risks for RNVA?
Regulatory compliance challenges and changes in healthcare policies.
- Competition from larger healthcare providers and hospital systems.
- Economic downturn affecting patient volumes and revenue.
- Negative P/E ratio and low profit margin indicating financial instability.
- Limited liquidity and potential price volatility due to OTC trading.
What Are RNVA's Competitive Advantages?
- Local presence in rural communities.
- Established healthcare facilities.
- Relationships with local physicians.
- Focus on underserved populations.
What Does RNVA Do?
Rennova Health, Inc. was founded in 2005 and is headquartered in West Palm Beach, Florida. The company operates in the healthcare services sector, primarily focusing on providing medical services through its subsidiaries. As of December 31, 2021, Rennova Health owns and operates one operating hospital in Oneida, Tennessee, an acute care hospital and a physician's practice in Jamestown, Tennessee, and a rural clinic in Williamsburg, Kentucky. These facilities offer a range of medical services to their respective communities. The company's operations are concentrated in providing healthcare access in rural areas, addressing the needs of underserved populations. Rennova Health aims to deliver quality patient care while navigating the complexities of the healthcare industry. The company's business model involves managing and operating healthcare facilities, providing medical services, and generating revenue through patient care and related services. Rennova Health faces competition from other healthcare providers and must adhere to regulatory requirements and industry standards to maintain its operations and market position.
What Products and Services Does RNVA Offer?
- Operates one hospital in Oneida, Tennessee.
- Manages an acute care hospital in Jamestown, Tennessee.
- Oversees a physician's practice in Jamestown, Tennessee.
- Runs a rural clinic in Williamsburg, Kentucky.
- Provides healthcare services to local communities.
- Focuses on acute care and general medical services.
How Does RNVA Make Money?
- Generates revenue through patient care services.
- Operates hospitals and clinics in rural areas.
- Provides acute care and general medical services.
- Manages physician practices.
What Industry Does RNVA Operate In?
Rennova Health operates within the healthcare services industry, which is characterized by increasing demand for medical services, technological advancements, and evolving regulatory landscapes. The industry is highly competitive, with numerous players ranging from large hospital chains to smaller clinics and specialized healthcare providers. Rennova Health's focus on rural healthcare positions it within a niche market, but it also faces challenges related to access to resources and skilled personnel. The company's success depends on its ability to adapt to industry trends, maintain regulatory compliance, and deliver quality patient care in a cost-effective manner.
Who Are RNVA's Key Customers?
- Residents of Oneida, Tennessee.
- Residents of Jamestown, Tennessee.
- Residents of Williamsburg, Kentucky.
- Patients seeking acute care services.
- Individuals requiring general medical care.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● No usable price
- ● No filing on record
- ● No analyst coverage
Insider Activity
12 transactions · 0 purchases, 0 sales, 12 other transactions · 6 identified insiders · most recent available transactions. Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.
RNVA Valuation & Market Position
With a $4.31M market cap, Rennova Health, Inc. sits in the micro-cap segment of the market.
Key Financial Metrics
Return on equity for Rennova Health, Inc. stands at 23.5%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -38.2%, showing how much profit it generates from its asset base. Its free cash flow yield is 70.5%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.16 means current liabilities exceed short-term assets, a liquidity point worth watching.
Financial Health
Rennova Health, Inc.'s Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile.
Company Profile
Rennova Health, Inc. operates in the Medical - Diagnostics & Research industry within the Healthcare sector. It is headquartered in West Palm Beach, US. The company is led by CEO Seamus Lagan. RNVA has traded publicly since 1995.
RNVA Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
RNVA Latest News
No recent news available for RNVA.
RNVA Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for RNVA.
Price Targets
Wall Street price target analysis for RNVA.
RNVA MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for RNVA; grades run from A+ (80-100) to F (below 30).
Leadership: Seamus Lagan
CEO
Seamus Lagan serves as the CEO of Rennova Health, Inc. His background includes experience in managing healthcare operations and driving strategic growth initiatives. He is responsible for overseeing the company's overall performance, developing and implementing business strategies, and ensuring compliance with regulatory requirements. His leadership is focused on improving patient care, enhancing operational efficiency, and creating value for shareholders.
Track Record: Under Seamus Lagan's leadership, Rennova Health has focused on maintaining its healthcare facilities and navigating the challenges of the healthcare industry. Key milestones include efforts to improve operational efficiency and enhance patient care services. He is focused on strategic decisions to improve the company's financial performance and market position.
RNVA OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Rennova Health may not meet the minimum financial standards or disclosure requirements for higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial reporting and may not be subject to the same level of regulatory scrutiny as companies listed on major exchanges like the NYSE or NASDAQ. This tier is often associated with higher risk and greater potential for volatility compared to exchange-listed stocks.
- OTC Tier: OTC Other
- Limited financial disclosure increases information asymmetry.
- Lower trading volume can lead to price volatility.
- Higher risk of fraud or manipulation compared to exchange-listed stocks.
- Potential for delisting or trading suspension.
- Limited regulatory oversight.
- Verify the company's financial statements and SEC filings (if any).
- Research the background and experience of the company's management team.
- Assess the company's business model and competitive landscape.
- Evaluate the company's legal and regulatory compliance.
- Review the company's ownership structure and shareholder base.
- Check for any history of fraud or regulatory violations.
- Consult with a qualified financial advisor.
- Operational healthcare facilities in multiple states.
- Experienced CEO with healthcare management background.
- History of providing healthcare services to local communities.
- Gross margin of 59.5% indicates potential in core operations.
- Focus on underserved populations.
What Investors Ask About Rennova Health, Inc. (RNVA) — Healthcare
What does Rennova Health, Inc. do?
Rennova Health, Inc. operates healthcare facilities, including hospitals and clinics, primarily in Tennessee and Kentucky. The company focuses on providing acute care and general medical services to local communities.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- Limited financial data available for Rennova Health, Inc.
- OTC market investments carry higher risk.